| Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissue M Marquié, MD Normandin, CR Vanderburg, IM Costantino, EA Bien, ... Annals of neurology 78 (5), 787-800, 2015 | 678 | 2015 |
| Elevated brain cannabinoid CB1 receptor availability in posttraumatic stress disorder: A positron emission tomography study A Neumeister, MD Normandin, RH Pietrzak, D Piomelli, MQ Zheng, ... Molecular psychiatry 18 (9), 1034, 2013 | 427 | 2013 |
| Rapid Changes in Cannabinoid 1 Receptor Availability in Cannabis-Dependent Male Subjects After Abstinence From Cannabis DC D’Souza, JA Cortes-Briones, M Ranganathan, H Thurnauer, ... Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 1 (1), 60-67, 2016 | 252 | 2016 |
| Pathological correlations of [F‐18]‐AV‐1451 imaging in non‐alzheimer tauopathies M Marquié, MD Normandin, AC Meltzer, M Siao Tick Chong, NV Andrea, ... Annals of neurology 81 (1), 117-128, 2017 | 214 | 2017 |
| In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer’s disease pathology and cognitive decline HIL Jacobs, JA Becker, K Kwong, N Engels-Domínguez, PC Prokopiou, ... Science Translational Medicine 13 (612), eabj2511, 2021 | 168 | 2021 |
| The cortical origin and initial spread of medial temporal tauopathy in Alzheimer’s disease assessed with positron emission tomography JS Sanchez, JA Becker, HIL Jacobs, BJ Hanseeuw, S Jiang, AP Schultz, ... Science Translational Medicine 13 (577), 2021 | 168 | 2021 |
| Neurovascular coupling to D2/D3 dopamine receptor occupancy using simultaneous PET/functional MRI CY Sander, JM Hooker, C Catana, MD Normandin, NM Alpert, ... Proceedings of the National Academy of Sciences 110 (27), 11169-11174, 2013 | 153 | 2013 |
| Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue C Aguero, M Dhaynaut, MD Normandin, AC Amaral, NJ Guehl, ... Acta Neuropathologica Communications 7 (1), 1-15, 2019 | 144 | 2019 |
| Striatal dopamine transporter availability in unmedicated bipolar disorder A Anand, G Barkay, M Dzemidzic, D Albrecht, H Karne, QH Zheng, ... Bipolar Disorders 13 (4), 406-413, 2011 | 130 | 2011 |
| In vivo imaging of endogenous pancreatic β-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET MD Normandin, KF Petersen, YS Ding, SF Lin, S Naik, K Fowles, ... Journal of Nuclear Medicine 53 (6), 908-916, 2012 | 129 | 2012 |
| Mature B cells accelerate wound healing after acute and chronic diabetic skin lesions RF Sîrbulescu, CK Boehm, E Soon, MQ Wilks, I Ilieş, H Yuan, B Maxner, ... Wound Repair and Regeneration 25 (5), 774-791, 2017 | 127 | 2017 |
| Imaging the Cannabinoid CB1 Receptor in Humans with [11C] OMAR: Assessment of Kinetic Analysis Methods, Test–Retest Reproducibility, and Gender Differences MD Normandin, MQ Zheng, KS Lin, NS Mason, SF Lin, J Ropchan, ... Journal of Cerebral Blood Flow & Metabolism 35 (8), 1313-1322, 2015 | 112 | 2015 |
| Heterogeneous effects of alcohol on dopamine release in the striatum: a PET study KK Yoder, CC Constantinescu, DA Kareken, MD Normandin, TE Cheng, ... Alcoholism: Clinical and Experimental Research 31 (6), 965-973, 2007 | 110 | 2007 |
| Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson’s case M Marquié, EE Verwer, AC Meltzer, SJW Kim, C Agüero, J Gonzalez, ... Acta Neuropathologica Communications 5 (1), 75, 2017 | 104 | 2017 |
| A linear model for estimation of neurotransmitter response profiles from dynamic PET data MD Normandin, WK Schiffer, ED Morris Neuroimage 59 (3), 2689-2699, 2012 | 98 | 2012 |
| Pharmacokinetic evaluation of the tau PET radiotracer 18F-T807 (18F-AV-1451) in human subjects DW Wooten, NJ Guehl, EE Verwer, TM Shoup, DL Yokell, N Zubcevik, ... Journal of Nuclear Medicine 58 (3), 484-491, 2017 | 97 | 2017 |
| [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging M Marquié, MST Chong, A Antón-Fernández, EE Verwer, ... Acta Neuropathologica, 1-10, 2017 | 96 | 2017 |
| Assessment of striatal dopamine transporter binding in individuals with major depressive disorder: In vivo Positron Emission Tomography and postmortem evidence DA Pizzagalli, S Berretta, D Wooten, F Goer, KT Pilobello, P Kumar, ... JAMA psychiatry 76 (8), 854-861, 2019 | 93 | 2019 |
| ntPET: a new application of PET imaging for characterizing the kinetics of endogenous neurotransmitter release ED Morris, KK Yoder, C Wang, MD Normandin, QH Zheng, B Mock, ... Molecular imaging 4 (4), 7290.2005. 05130, 2005 | 85 | 2005 |
| Discovery of a Highly Selective Glycogen Synthase Kinase‐3 Inhibitor (PF‐04802367) That Modulates Tau Phosphorylation in the Brain: Translation for PET Neuroimaging SH Liang, JM Chen, MD Normandin, JS Chang, GC Chang, CK Taylor, ... Angewandte Chemie International Edition 55 (33), 9601-9605, 2016 | 84 | 2016 |